CONMED | CNMD - Cash And Equivalent


CONMED reported $37.33M in Cash and Equivalent for its fiscal quarter ending in June of 2026.





Cash And Equivalent Change Date
3M USD 4.84B 1.88B Sep/2026
Abbott USD 4.05B 1.05B Sep/2026
Accuray USD 41.29M 22.05M Dec/2025
AtriCure USD 187.03M 19.24M Sep/2026
Baxter International USD 1.98B 175M Sep/2026
Becton, Dickinson and Co. USD 725M 17M Sep/2026
Boston Scientific USD 609M 70M Sep/2026
CONMED USD 37.33M 2.3M Jun/2026
Cooper Companies USD 138.8M 13.9M Mar/2026
Dexcom USD 961.4M 143.6M Sep/2026
Edwards Lifesciences USD 3.11B 210.8M Sep/2026
Globus Medical USD 441.27M 66.47M Sep/2026
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 584.4M 49.5M Sep/2026
Integra LifeSciences USD 252.26M 37.85M Sep/2026
Intuitive Surgical USD 6.8B 1.83B Sep/2026
J&J USD 16.91B 3.51B Sep/2026
Medtronic USD 1.69B 258M Jun/2026
Merit Medical Systems USD 503.55M 54.85M Sep/2026
Olympus JPY 157.74B 10.5B Sep/2026
Orthofix International USD 86.32M 17.49M Sep/2026
ResMed USD 1.01B 458.49M Sep/2026
Steris USD 482.3M 42.7M Jun/2026
Stryker USD 3.27B 120M Sep/2026
Tandem Diabetes Care USD 72.84M 10.02M Sep/2026
Teleflex USD 430.46M 130.31M Sep/2026
Zimmer Biomet Holdings USD 399.9M 10.1M Sep/2026